Prognostic Score and Benefit from Abiraterone in First-line Metastatic, Castration-resistant Prostate Cancer Citation: Lorente D, Llacer C, Lozano R, et al. Eur Urol. 2021 Nov;80(5):641-649. Epub 2021 Aug 6. PMID: 34373138.
The YODA Project